Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-26 @ 1:16 PM
Ignite Modification Date: 2025-12-26 @ 1:16 PM
NCT ID: NCT01732406
Description: None
Frequency Threshold: 0
Time Frame: This was a cross-sectional study. Adverse events were collected at the baseline cross-sectional visit for each subject.
Study: NCT01732406
Study Brief: Acromegaly Treatment Quality of Life Study
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Acromegaly on Pegvisomant Patients receiving pegvisomant monotherapy from own doctor to treat acromegaly. 0 None 0 31 0 31 View
Acromegaly on Somatostatin Analog Patients receiving somatostatin analog monotherapy from own doctor to treat acromegaly. 0 None 0 60 0 60 View
Active Acromegaly Patients receiving no medications to treat active acromegaly. 0 None 0 35 0 35 View
Serious Events(If Any):
Other Events(If Any):